These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 1385839)
1. Remodeling of the heart (membrane proteins and collagen) in hypertensive cardiopathy. Sainte Beuve C; Leclercq C; Rannou F; Oliviero P; Mansier P; Chevalier B; Swynghedauw B; Charlemagne D Kidney Int Suppl; 1992 Jun; 37():S45-50. PubMed ID: 1385839 [TBL] [Abstract][Full Text] [Related]
2. Origin and mechanisms of heart failure in hypertensive patients: left ventricular remodelling in hypertensive heart disease. Dubus I; Samuel JL; Swynghedauw B Eur Heart J; 1993 Nov; 14 Suppl J():76-81. PubMed ID: 8281969 [TBL] [Abstract][Full Text] [Related]
3. Physiologic versus pathologic hypertrophy and the pressure-overloaded myocardium. Weber KT; Clark WA; Janicki JS; Shroff SG J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S37-50. PubMed ID: 2485029 [TBL] [Abstract][Full Text] [Related]
4. Remodeling of the heart in chronic pressure overload. Swynghedauw B Basic Res Cardiol; 1991; 86 Suppl 1():99-105. PubMed ID: 1645166 [TBL] [Abstract][Full Text] [Related]
5. Cardiac hypertrophy and failure--a disease of adaptation. Modifications in membrane proteins provide a molecular basis for arrhythmogenicity. Moalic JM; Charlemagne D; Mansier P; Chevalier B; Swynghedauw B Circulation; 1993 May; 87(5 Suppl):IV21-6. PubMed ID: 8485830 [TBL] [Abstract][Full Text] [Related]
14. [Biological bases of ventricular remodeling]. Swynghedauw B Arch Mal Coeur Vaiss; 1993 Feb; 86 Spec No 2():41-4. PubMed ID: 8215789 [TBL] [Abstract][Full Text] [Related]
15. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?]. Brilla CG; Schencking M; Scheer C; Rupp H Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851 [TBL] [Abstract][Full Text] [Related]
16. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction. Timmers L; van Keulen JK; Hoefer IE; Meijs MF; van Middelaar B; den Ouden K; van Echteld CJ; Pasterkamp G; de Kleijn DP Circ Res; 2009 Mar; 104(5):699-706. PubMed ID: 19168865 [TBL] [Abstract][Full Text] [Related]
17. Diastolic function in valvular heart disease. Hess OM; Felder L; Krayenbuehl HP Herz; 1991 Apr; 16(2):124-9. PubMed ID: 1829706 [TBL] [Abstract][Full Text] [Related]
18. [Heart effect of arterial hypertension. Heart hypertrophy as a risk factor. Study technics (electrocardiogram, echocardiography, exercise test and Holter]. Aguilera Saldaña MA; García Moreno LM; Rodríguez Padial L; Navarro Lima A; Sánchez Domínguez J Rev Esp Cardiol; 1990; 43 Suppl 1():54-64. PubMed ID: 2139976 [TBL] [Abstract][Full Text] [Related]
19. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure. Kobayashi M; Machida N; Mitsuishi M; Yamane Y Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617 [TBL] [Abstract][Full Text] [Related]